Laman UtamaPGEN • NASDAQ
add
Precigen Inc
$0.90
Selepas Waktu Dagangan:(0.48%)-0.0043
$0.90
Tutup: 22 Nov, 8:00:00 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$0.90
Julat hari
$0.89 - $0.97
Julat tahun
$0.78 - $1.93
Permodalan pasaran
258.56J USD
Bilangan Purata
747.73K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 953.00K | -30.89% |
Perbelanjaan pengendalian | 21.21J | 2.05% |
Pendapatan bersih | -23.98J | -21.13% |
Margin untung bersih | -2.52K | -75.28% |
Pendapatan bagi setiap syer | -0.09 | -12.50% |
EBITDA | -20.59J | -6.75% |
Kadar cukai berkesan | -0.05% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 28.63J | -61.18% |
Jumlah aset | 83.47J | -56.22% |
Jumlah liabiliti | 28.10J | -34.67% |
Jumlah ekuiti | 55.38J | — |
Syer tertunggak | 292.87J | — |
Harga kepada buku | 4.75 | — |
Pulangan pada aset | -67.87% | — |
Pulangan pada modal | -96.09% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -23.98J | -21.13% |
Tunai daripada operasi | -22.73J | -33.66% |
Tunai daripada pelaburan | 5.65J | -46.29% |
Tunai daripada pembiayaan | 32.13J | — |
Perubahan bersih dalam tunai | 15.12J | 328.46% |
Aliran tunai bebas | -14.67J | -61.55% |
Perihal
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Diasaskan
21 Mei 1998
Tapak web
Pekerja
202
